0% found this document useful (0 votes)
50 views13 pages

Relative Resource Manager

This document discusses upper gastrointestinal dysfunctions including the oral cavity, esophagus, and stomach. It provides objectives to identify common dysfunctions, risk factors, causes, pathophysiology, clinical manifestations, and treatment approaches. Specific conditions covered include malnutrition, oral cancer, gastritis, and acute and chronic gastritis. Risk factors, diagnosis, management, and clinical manifestations are described for several of these conditions.

Uploaded by

jazmemon
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
50 views13 pages

Relative Resource Manager

This document discusses upper gastrointestinal dysfunctions including the oral cavity, esophagus, and stomach. It provides objectives to identify common dysfunctions, risk factors, causes, pathophysiology, clinical manifestations, and treatment approaches. Specific conditions covered include malnutrition, oral cancer, gastritis, and acute and chronic gastritis. Risk factors, diagnosis, management, and clinical manifestations are described for several of these conditions.

Uploaded by

jazmemon
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 13

Upper gastrointestinal dysfunction

– oral, oesophageal and gastric

Prepared by Gabrielle Metelli - 2009

University of Western Sydney

Objectives
¾ Identify common dysfunctions of the upper gastrointestinal tract
(GIT) – oral, oesophageal and gastric.
¾ Describe the risk factors that can lead to the development of these
dysfunctions.
¾ Identify causes, mechanism and treatment of upper GIT
dysfunctions.
¾ Describe the pathophysiology, clinical manifestations and treatment
for upper GIT dysfunctions.

University of Western Sydney 2


2009 UANE&S

1
MALNUTRITION
¾ Results from inadequate intake of nutrients.
¾ May be caused by
¾ Inadequate nutrient intake
¾ Impaired absorption and use of nutrients
¾ Loss of nutrients
¾ Increased metabolic needs

¾ Incidence & Prevalence

¾ Widespread cause of disease & mortality.

¾ It is estimated that approx. ½ of all hospitalised patients are


malnourished either on admission or develop due to surgery or
serious illness.
University of Western Sydney 3
2009 UANE&S

¾ RISK FACTORS ¾ MANIFESTATIONS


¾ Age ¾ Weight loss
¾ Poverty, homelessness, inadequate ¾ Weakness, listlessness
food storage/preparation facilities ¾ Loss of subcutaneous fat
¾ Limited mobility/vision ¾ Muscle wasting/cramping
¾ Oral/GIT problems affecting food ¾ Thin/sparse hair
intake, digestion & absorption ¾ Flaking/dry/scaling/rough skin
¾ Inability to eat for ≥5 days ¾ Hepatomegaly
¾ Chronic pain/diseases ¾ Night blindness
¾ Dementia, mental health disorders ¾ Altered taste & smell
¾ Appetite affecting ¾ Confusion, apathy
medications/treatments
¾ Cardiomegaly, dyspnoea
¾ Alcohol/drug addiction
¾ Paresthesias, neuropathy, ataxia
¾ Acute problems – infection, surgery,
trauma ¾ Glossitis, stomatitis, swollen/bleeding
gums
¾ Delayed healing
¾ Easy bruising

University of Western Sydney 4


2009 UANE&S

2
¾ Diagnosis ¾ Management

¾ Serum albumin & prealbumin ¾ Careful reintroduction of fluids


¾ Total lymphocyte count & nutrients to correct fluid &
¾ Serum electrolytes electrolyte imbalances
¾ Bioelectric impedance analysis ¾ Gradual introduction of protein
and calories
¾ Total daily energy expenditure
¾ Vitamin & mineral
supplements

¾ AIM – pt. to gain 1.5-


2kg/week
¾ Methods
¾ Enteral nutrition (tube)
¾ Parenteral nutrition (IV)
University of Western Sydney 5
2009 UANE&S

Oral Cancer
¾ Oral cancer is a serious public health problem,
¾ with over 200,000 new cases reported annually worldwide,

¾ Two-thirds of which occur in developing countries.

¾ The overall mortality rate for intra-oral cancer remains high


¾ at approx. 50%, even with modern medical services,
¾
¾ Most likely due to the advanced stage of the disease at presentation.

¾ Major risk factors for oral cancer worldwide,


¾ notably tobacco, alcohol and betel quid

¾ Oral cancer predominantly affects


¾ the socially disadvantaged, residing in deprived areas.
University of Western Sydney (Walker, Boey, & McDonald, 2003) 6
2009 UANE&S

3
Major Risk Factors for Oral Cancer
Tobacco Alcohol Betel Quid Dietary Factors
¾ >300 ¾ Alcohol has ¾Betel quid chewing produces ¾A low intake of fresh fruits &
carcinogens & local effects e.g., reactive oxygen species (ROS) vegetables is linked to an
pro-carcinogens direct actions on increased risk of oral cancer.
found in cell membranes, ¾These have multiple
tobacco smoke alteration in detrimental effects on oral ¾Vegetables & fruits that protect
or its water- mucosal mucosa. against oral cancer & pre-cancer
soluble permeability, are rich in b-carotene, vitamin C
compounds. variation in tissue & vitamin E with anti-oxidant
distribution and ¾ROS directly involved in
tumour initiation process, properties.
¾ These
contaminate ¾ systemic effects, ¾Iron deficiency can result in oral
saliva. e.g., nutritional ¾Induces genotoxicity & gene
mutation or attacks salivary epithelial atrophy & development
deficiencies, of cancer of upper airways and
immunological proteins & oral mucosa,
food passages
deficiencies &
disturbed liver ¾Leads to structural change in
function oral mucosa which allows ¾Dietary iron plays a protective
penetration by other BQ role in maintaining the thickness
ingredients & environmental of oral epithelium.
toxins.
¾Dietary fat & red meat may be
risk factors for cancer of head and
neck.
(Walker, Boey, & McDonald, 2003
University of Western Sydney 7
2009 UANE&S

¾ Clinical Manifestations ¾ Treatment

¾ White patches ¾ Eliminate any causative factor/s


¾ Red patches ¾ Tumour staging then determines
¾ Ulcers therapy
¾ Masses ¾ Radiation therapy
¾ Pigmented areas ¾ Chemotherapy
¾ Fissures ¾ Surgery
¾ Asymmetry of head, face, jaws, or
neck

University of Western Sydney 8


2009 UANE&S

4
www.naturalypure.com
University of Western Sydney 9
2009 UANE&S

Gastritis
¾ Definition
¾ inflammation of the gastric mucosa and one of the most common disorders of
the GIT system.

¾ acute or chronic.

¾ Can affect the fundus or antrium or both.

¾ Acute gastritis erodes the surface epithelium in a localised pattern


¾ often superficial.

¾ Can also be diffuse pattern of inflammation

University of Western Sydney 10


2009 UANE&S

5
¾ ACUTE GASTRITIS ¾ CHRONIC GASTRITIS
¾ Usually a result of injury of ¾ 3 FORMS : gastric secretion
protective mucosal barrier progressively fails
¾ caused by drugs, IRR and
chemotherapy
¾ SUPERFICIAL – marked
inflammation causes
¾ Short term inflammation ¾ reddened, oedematous mucosa with
small erosions and haemorrhage.
¾ Causes & contributing factors
¾ Alcohol, ¾ ATROPHIC – occurs in all layers &
¾ histamine, frequently develops in association
¾ digitalis with gastric ulcer & gastric cancer.
¾ Characterized by a decreased no. of
¾ metabolic disorders - uraemia parietal & chief cells.
(associated with renal/respiratory
failure or cirrhosis).
¾ HYPERTROPHIC – produces dull &
nodular mucosa with irregular,
¾ Highest incidence - men in the 5th thickened or nodular rugae –
and 6th decades of life. hemorrhages occur frequently.

¾ Incidence greater in smokers and


heavy drinkers,
University of Western Sydney 11
2009 UANE&S

ETIOLOGY & RISK FACTORS - chronic


¾ PUD
¾ infection with Helibactor pylori
¾ this can lead to gastric cancer.

¾ Gastric surgery
¾ bile and acids may reflux into the remaining stomach, causing
gastritis.

¾ Age

University of Western Sydney 12


2009 UANE&S

6
Pathophysiology
¾ Acute Gastritis ¾ Chronic Gastritis
¾ Mucosal lining of the stomach is ¾ In the beginning – similar to acute
protected against the HCl. gastritis.
¾If barrier penetrated, mucosa ¾ Lining first becomes thick and red
becomes injured. and then thin and atrophic.
¾ HCl comes in contact with the ¾ Atrophy causes loss of function
mucosa, injury to small
¾ When acid decreases the source of
vessels occurs
intrinsic factor is lost.
¾oedema, hemorrhage and
possible ulcer formation. ¾ Ulcers and bleeding can occur
¾ Damage assoc. with acute gastritis resulting in minimal
is usually limited. amounts of acid secreted
¾ Damage to the mucosa can occur (achlohydria) a predisposer
within minutes to gastric cancer.
¾ outcome depends upon the
severity and extent of the
damage.
University of Western Sydney 13
2009 UANE&S

CLINICAL MANIFESTATIONS
¾ Acute Gastritis ¾ Chronic Gastritis
¾ Abdominal tenderness ¾ S & S may be vague and even
¾ epigastric discomfort absent
¾ cramping
¾ Belching ¾ no increase in the secretion of HCl,
¾ reflux & severe n/v
¾ Headache & Low grade fever ¾ anorexia, feeling of fullness,
¾ If contaminated food diarrhoea within
5 hours of ingestion ¾ belching, nausea,
¾ malaise
¾ epigastric pain or intolerance to
¾ Potent corrosive chemical can cause
peritonitis spicy foods.
¾ Painless GI bleeding
¾ Malaena.
¾ sometimes haematemesis
¾ haemorrhage (tachycardia,
hypotension, vertigo, restlessness,
pallor)

University of Western Sydney 14


2009 UANE&S

7
¾ Diagnostic tests - acute ¾ Diagnostic tests - chronic
¾ Stool (occult) test
¾ FBC,
¾ Full blood test-Hb and
hematocrit ¾ Vit B12,
(inflammation, ¾ endoscopy.
haemorrhage) ¾ Stool (occult) test
¾ Endoscopy- oesophago-gastro-
¾ Detailed history of food and
duodenoscopy medications
¾ Endoscopy- oesophago-gastro-
¾ Gastric analysis to assess duodenoscopy
hydrochloric acid
secretion

¾B12 levels

¾ Detailed history of food and


medications

University of Western Sydney 15


2009 UANE&S

MANAGEMENT
¾ Chronic
¾ Acute
¾ Diagnosis – rule out gastric cancer.
¾ Remove the cause.
¾ Diet – client eats what suits them,
¾ Treat the vomiting small frequent meals
¾ Antacids or histamine(H2) ¾ Lifestyle education – stop smoking,
receptor antagonists NBM until reduce alcohol, decrease caffeine,
vomiting subsides regular check ups
¾ Liquid diet and liquid antacids ¾ Antacids – Mylanta to relieve
¾ IV therapy discomfort
¾ Return to normal diet when ¾ H.pylori – a combination of drugs –
feeling able Losec, Flagyl. Regime given over a
¾ Gastric lavage week and can be repeated.
¾ Prevent complications- ¾ Vit B12 (for life, Cobalamin),
haemorrhage and peritonitis corticosteroids (attempt to regenerate
parietal cells), ranitidine are often
ordered.
University of Western Sydney 16
2009 UANE&S

8
COMPLICATIONS - chronic
¾ Bleeding
¾ Pernicious Anaemia
¾ lack of intrinsic factor.
¾ B12 needed in formation of RBC, nerve cell function – (fatigue, parathesias,
SOB, diarrhoea, ataxia
¾ Gastric cancer - adenocarcinoma

SURGICAL MANAGEMENT
Surgery may be required to control the bleeding
¾ subtotal gastrectomy
¾ (partial removal of the stomach)
¾ Pyloroplasty
¾ widening of the pylorus enhancing gastric emptying.
¾ Vagotomy
¾ cutting of the right and left vagus nerves – eliminates acid-secreting stimulus to
the gastric cells.
University of Western Sydney 17
2009 UANE&S

PEPTIC ULCER DISEASE


¾ Involves a break in the continuity of the oesophageal, gastric or
duodenal mucosa.

¾ Corrosive action of HCl and pepsins in the gastric secretions on the


exposed mucosa cause necrosis and ulceration

¾ Occurs in any part of the GI tract in contact with gastric juices.

¾ Occurs in approx. 10% of the population.

¾ Men more likely to have gastric and duodenal ulcers.

¾ Acute / chronic – gastric / duodenal

University of Western Sydney 18


2009 UANE&S

9
DUODENAL ULCERS GASTRIC ULCERS
¾ Greater incidence ¾ Most common area - within 2.5cm
of the pylous
¾ Hypersecretion of acid is the ¾ these heal within weeks.
greatest cause. ¾ Cause
¾ break in the mucosa.
¾ Clients with a duodenal ulcer ¾ Incompetent pylorus may decrease
experience low pH levels in the the production of mucus
duodenum for longer periods – ¾ which allows reflux of bile into the
¾ the stomach lining is more sensitive stomach (corrosive).
to gastrin & secretes excess gastrin
¾ Decreased blood flow to the gastric
mucosa may also alter the
¾ More rapid gastric emptying occurs
defensive barrier
and
¾ in combination with hypersecretion ¾ leading to breaks in the mucosa.
causes large acid load in duodenum.

University of Western Sydney 19


2009 UANE&S

ETIOLOGY AND RISK FACTORS


¾ H.pylori – cause in almost 90% of all peptic ulcers.
¾ Ulceration occurs when aggressive factors exceed the defensive barrier.
¾ Risk factors – NSAID, steroids, smoking, caffeine, stress and alcohol

PATHOPHYSIOLOGY
¾ 2 different mechanisms for development of PUD :
¾ breakdown of the protective epithelial lining
¾ Stress

¾ Zollinger –Ellison syndrome is characterised by abnormal secretion of


gastrin by a rare islet tumor in the pancreas.
¾ These clients have diarrhoea secondary to fat malabsorption - steatorrhea.
¾ Treatment is aimed at suppression of acid secretion.

University of Western Sydney 20


2009 UANE&S

10
health.yahoo.com/topic/digestive/overview/ar

t... University of Western Sydney 21


2009 UANE&S

Clinical Manifestations
¾ GASTRIC ¾ DUODENAL

¾ Pain on eating, can be variable ¾ Pain on empty stomach


¾ Antacids ineffective ¾ Relieved by food and antacids
¾ Usually well nourished ¾ Often malnourished
¾ Haematemesis more common ¾ Malaena more common than
than malaena haematemesis
¾ Recurrence unlikely after surgery ¾ Recurrence as marginal ulcers
after surgery

University of Western Sydney 22


2009 UANE&S

11
DIAGNOSIS
¾ Clinical manifestations
¾ Endoscopy and biopsy
¾ FBC
¾ testing for H.pylori – via urea breath tests

MANAGEMENT
¾ Provide rest for the stomach
¾ H.pylori – use medication regime
¾ Reduce gastric secretions
¾ Strengthen mucosal barrier
¾ Diet

University of Western Sydney 23


2009 UANE&S

COMPLICATIONS SURGERY
¾ Haemorrhage ¾ Subtotal gastrectomy
¾ Pyloroplasty
¾ Treatment for shock
¾ Vagotomy 3 types:
¾ Vasopression – for haemorrhage
¾ Truncal
¾ Rest – administer analgesia
¾ Selective
¾ PERFORATION – a surgical
emergency ¾ Proximal
¾ Surgery ¾ Gastrectomy
¾ Pain ¾ Gastroenterostomy
¾ IV fluids
¾ IV antibiotics +++++ ¾ Antrectomy

University of Western Sydney 24


2009 UANE&S

12
Bibliography
¾ Black, J. M., Hawks, J., & Keene, A. M. (2004). Medical-surgical nursing: Clinical
management. (7th ed.). Philadelphia: W. B. Saunders.

¾ Lehne, R. A .(2007). Pharmacology for nursing care. (6th ed.). St.Louis: Saunders
Elsevier.

¾ Lemone, P., & Burke, K. (2007). Medical surgical nursing. Critical thinking
in client care. (4th ed.). Upper Saddle River, New Jersey:Prentice Hall.

¾ Lemone, P., & Burke, K. (2004). Medical surgical nursing. Critical thinking
in client care. (3rd ed.). Upper Saddle River, New Jersey:Prentice Hall.

¾ McCance, K. L., & Heuther, S. E. (2002). Pathophysiology: The biologic basis for
disease in adults and children. (4th ed.). St. Louis : C.V.Mosby.

¾ Walker, D., Boey, G., & McDonald, L. (2003). The pathology of oral cancer.
Pathology, 35(5), 376-383.

University of Western Sydney 25


2009 UANE&S

13

You might also like